194 related articles for article (PubMed ID: 23720837)
21. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein in patients with COPD, control smokers and non-smokers.
Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
[TBL] [Abstract][Full Text] [Related]
23. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
24. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease.
Soeda S; Ohyashiki JH; Ohtsuki K; Umezu T; Setoguchi Y; Ohyashiki K
Int J Mol Med; 2013 Mar; 31(3):533-9. PubMed ID: 23338559
[TBL] [Abstract][Full Text] [Related]
26. Complement factor C5a in acute exacerbation of Chronic Obstructive Pulmonary Disease.
Marc MM; Kristan SS; Rozman A; Kern I; Flezar M; Kosnik M; Korosec P
Scand J Immunol; 2010 May; 71(5):386-91. PubMed ID: 20500690
[TBL] [Abstract][Full Text] [Related]
27. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
[TBL] [Abstract][Full Text] [Related]
28. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
[TBL] [Abstract][Full Text] [Related]
29. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
Hurst JR; Donaldson GC; Perera WR; Wilkinson TM; Bilello JA; Hagan GW; Vessey RS; Wedzicha JA
Am J Respir Crit Care Med; 2006 Oct; 174(8):867-74. PubMed ID: 16799074
[TBL] [Abstract][Full Text] [Related]
30. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.
Biljak VR; Pancirov D; Cepelak I; Popović-Grle S; Stjepanović G; Grubišić TŽ
Platelets; 2011; 22(6):466-70. PubMed ID: 21506665
[TBL] [Abstract][Full Text] [Related]
31. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K
Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
[TBL] [Abstract][Full Text] [Related]
32. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
[TBL] [Abstract][Full Text] [Related]
33. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease.
Kristan SS; Marc MM; Kern I; Flezar M; Suskovic S; Kosnik M; Korosec P
Scand J Immunol; 2012 Jan; 75(1):109-14. PubMed ID: 21916917
[TBL] [Abstract][Full Text] [Related]
34. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
[TBL] [Abstract][Full Text] [Related]
35. [Correlation between serum marker variations and pulmonary hypertension secondary to chronic obstructive pulmonary disease].
Xie X; Wang X; Zhang Y; Han D; Li S; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1458-62. PubMed ID: 24144746
[TBL] [Abstract][Full Text] [Related]
36. Effect of corticosteroids on hemostasis and pulmonary arterial pressure during chronic obstructive pulmonary disease exacerbation.
Kunter E; Ilvan A; Ozmen N; Demirer E; Ozturk A; Avsar K; Sayan O; Kartaloğlu Z
Respiration; 2008; 75(2):145-54. PubMed ID: 17143000
[TBL] [Abstract][Full Text] [Related]
37. COPD: magnesium in the plasma and polymorphonuclear cells of patients during a stable phase.
Ruljancic N; Popovic-Grle S; Rumenjak V; Sokolic B; Malic A; Mihanovic M; Cepelak I
COPD; 2007 Mar; 4(1):41-7. PubMed ID: 17364676
[TBL] [Abstract][Full Text] [Related]
38. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
[TBL] [Abstract][Full Text] [Related]
39. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
Barouchos N; Papazafiropoulou A; Iacovidou N; Vrachnis N; Barouchos N; Armeniakou E; Dionyssopoulou V; Mathioudakis AG; Christopoulou E; Koltsida S; Bassiakou E
Scand J Clin Lab Invest; 2015 Apr; 75(2):126-32. PubMed ID: 25598350
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
